Mayer Toby K, Koehler Andreas, Eyssel Jana, Nieder Timo O
Interdisciplinary Transgender Health Care Center Hamburg, Institute for Sex Research and Forensic Psychiatry, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.
J Clin Med. 2019 May 26;8(5):749. doi: 10.3390/jcm8050749.
The gender identity of trans individuals influences their treatment preferences, and this in turn seems to affect their individual treatment progress. However, there has been no research which-next to the impact of gender identity on treatment desires-has also investigated the influence of treatment progress using a measure which assumes various possible transition pathways of trans persons.Therefore, an online community survey of trans people was conducted in Germany in 2015. Data were collected via an online survey from a non-clinical sample of = 415 trans individuals (over half assigned female at birth), aged 16-76 (Mean () = 38.12). Almost one fifth of participants embraced non-binary or genderqueer (NBGQ) identities. Participants progressed 60.77% (standard deviation () = 35.21) through treatment at point of data collection, as measured by the individual treatment progress score (ITPS). All participants, especially participants assigned male at birth, differed significantly in desire to participate in decision-making processes based on transition progress; individuals without treatment experience had less desire to decide treatment plans. NBGQ participants assigned male at birth in early stages of transition had significantly more desire for psychotherapy during transition than participants of the same identity in later transition stages. All participants, especially binary participants, significantly differed in desire for aftercare based on transition progress; individuals without treatment experience indicated more desire for aftercare. Results indicate health professionals should expect changing treatment desires in trans individuals at various stages of transition, particularly at treatment start, and based on gender identity.
跨性别者的性别认同会影响他们的治疗偏好,而这反过来似乎又会影响他们的个体治疗进程。然而,除了性别认同对治疗意愿的影响之外,目前还没有研究使用一种考虑到跨性别者各种可能转变途径的方法来调查治疗进程的影响。因此,2015年在德国对跨性别者进行了一项在线社区调查。数据通过在线调查从415名跨性别者的非临床样本中收集(超过一半出生时被指定为女性),年龄在16 - 76岁之间(平均()= 38.12)。近五分之一的参与者认同非二元或性别酷儿(NBGQ)身份。根据个体治疗进程得分(ITPS)衡量,在数据收集时,参与者在治疗中的进展为60.77%(标准差()= 35.21)。所有参与者,尤其是出生时被指定为男性的参与者,在基于转变进展参与决策过程的意愿上存在显著差异;没有治疗经验的个体对决定治疗计划的意愿较低。处于转变早期的出生时被指定为男性的NBGQ参与者比处于转变后期的相同身份参与者在转变期间对心理治疗有明显更高的意愿。所有参与者,尤其是二元身份的参与者,在基于转变进展对后续护理的意愿上存在显著差异;没有治疗经验的个体表示对后续护理有更高的意愿。结果表明,医疗专业人员应该预期跨性别者在转变的各个阶段,特别是在治疗开始时,会根据性别认同改变治疗意愿。